In this document, we look at the actions we are taking and those that as a field we all need to take to transform prevention “options” developed through research into prevention “choices” for people that can save lives and help end epidemics. This work is critical, and it is shared – just as we developed our strategic plan and EDI statement in partnership with so many, so too will we move this work forward, together.
Advocate, Translate, Catalyze: For HIV prevention and health equity
20 Essential Resources – Condoms & Family Planning
As recent-day family planning and reproductive health efforts place greater emphasis on innovation, it is important to remember the value of evidence-based family planning tools that have been effective for decades. Since the physical properties of condoms have not undergone substantial change, many people may forget the power of condoms as a family planning tool. This collection was created as a reminder to all of us that some methods continue to work even as innovations arise.
Global Investment in HIV Cure Research and Development in 2020
In 2014, the HIV Vaccines and Microbicides Resource Tracking Working Group and AVAC began a collaboration with the International AIDS Society’s (IAS) Towards an HIV Cure initiative. AVAC, Treatment Action Group (TAG) and the IAS brought together a group to review and allocate grants towards HIV cure research and analyze data on global funding. The working group released a report in July 2021, Global Investment in HIV Cure Research and Development in 2020.
A Situation Analysis Report on the Mobilization of Resources for Health Research & Development in Africa
This is a report commissioned by WACI Health in an effort to identify gaps, strengths and opportunities in health research funding. This aims at informing strategy and advocacy for all stakeholders committed to expanding the resources for health research and development (R&D) in Africa drawing from the experience and lessons from existing health R&D investments.
Access to the Dapivirine Vaginal Ring: A timeline on progress
This infographic shows the timeline of progress for end user access to Dapivirine Vaginal Ring.
Future Prospects for New Vaccines Against Sexually Transmitted Infections
This review provides an update on the need, development status, and important next steps for advancing development of vaccines against sexually transmitted infections (STIs), including herpes simplex virus (HSV), Neisseria gonorrhoeae (gonorrhea), Chlamydia trachomatis (chlamydia), and Treponema pallidum (syphilis).
Undetectable = Untransmittable Resources
This website from the Prevention Access Campaign is filled with links to the latest information on Undetectable = Untransmittable as well as other pertinent documents and resources.
PEPFAR-Funded PrEP and VMMC Services in 14 Priority Countries
This infographic shows that PEPFAR’s increased investment and creation of a budget code resulted in improved scale-up of VMMC (VMMC). A budget code could have the same impact if applied to PrEP initiations.
Illustrated Glossary for Long-Acting Technologies
Language is important and how affected communities become familiarized with the technical aspects in emerging fields, such as nanomedicines to treat HIV, hepatitis C virus, TB and malaria, is an essential part of meaningful, equitable engagement in early stage science. The Illustrated Glossary for Long-Acting Technologies compiles frequent terms and concepts used in the research and development of long-acting technologies. The glossary is a non-exhaustive list and the graphics are artistic renderings meant to spur discussion and assist with community treatment literacy.
2021 Pipeline Report
The Treatment Action Group Pipeline Report provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV) and tuberculosis (TB).
Read the report on the Treatment Action Group website.